Annual Drug Patent Expirations for COMBIVENT+RESPIMAT
Combivent Respimat is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug.
This drug has one hundred and fifty-four patent family members in forty-four countries.
The generic ingredient in COMBIVENT RESPIMAT is albuterol sulfate; ipratropium bromide. One supplier is listed for this compound. Additional details are available on the albuterol sulfate; ipratropium bromide profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
